Cargando…
1273. Efficacy of Cefiderocol against carbapenem-resistant A. baumannii and P. aeruginosa in ventilator-associated pneumonia mouse model
BACKGROUND: Cefiderocol (CFDC) is a novel cephalosporin with siderophore structure, characterized by transportation through siderophore receptor on outer membrane of Gram-negative bacteria and structural stability against beta-lactamase. The antimicrobial activity against multidrug resistant bacteri...
Autores principales: | Ota, Kenji, Kaku, Norihito, Uno, Naoki, Sakamoto, Kei, Kosai, Kosuke, Hasegawa, Hiroo, Miyazaki, Taiga, Izumikawa, Koichi, Mukae, Hiroshi, Yanagihara, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777080/ http://dx.doi.org/10.1093/ofid/ofaa439.1457 |
Ejemplares similares
-
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018) -
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017) -
Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model
por: Morinaga, Yoshitomo, et al.
Publicado: (2019) -
Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan?
por: Kaku, Norihito, et al.
Publicado: (2021) -
Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples
por: Ota, Kenji, et al.
Publicado: (2021)